Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > FDS´s unique strategy

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Oct 11, 2021 7:13pm

114 Views

Post# 33995783

RE:FDS´s unique strategy

Pumping on a holiday should get you banned....especially when it's for FSD........

Juliettepe wrote: A unique strategy to treating neurodegenerative disorders called "Total Brain Health" will be applied by FSD Pharma through the acquisition of Lucid Pharmaceuticals, which will enter the medical psychedelics market. Although it is an early stage industry, the potential of psychedelic health care is growing, and the market is expected to reach 10.75 billion US dollars by 2027.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China